KEROS THERAPEUTICS INC's ticker is KROS and the CUSIP is 492327101. A total of 103 filers reported holding KEROS THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $322,147 | -20.7% | 10,105 | 0.0% | 0.04% | -34.9% |
| Q2 2023 | $406,019 | +94103.9% | 10,105 | 0.0% | 0.06% | -7.4% |
| Q1 2023 | $431 | -11.1% | 10,105 | 0.0% | 0.07% | -40.4% |
| Q4 2022 | $485 | -99.9% | 10,105 | 0.0% | 0.11% | +28.1% |
| Q3 2022 | $380,000 | +36.2% | 10,105 | 0.0% | 0.09% | +34.8% |
| Q2 2022 | $279,000 | -49.3% | 10,105 | 0.0% | 0.07% | -12.0% |
| Q1 2022 | $550,000 | -6.9% | 10,105 | 0.0% | 0.08% | -5.1% |
| Q4 2021 | $591,000 | +47.8% | 10,105 | 0.0% | 0.08% | +38.6% |
| Q3 2021 | $400,000 | -6.8% | 10,105 | 0.0% | 0.06% | +21.3% |
| Q2 2021 | $429,000 | – | 10,105 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 396,911 | $21,584,000 | 5.10% |
| Deep Track Capital, LP | 1,380,306 | $75,061,000 | 4.81% |
| Opaleye Management Inc. | 265,750 | $14,451,000 | 4.49% |
| Octagon Capital Advisors LP | 340,214 | $18,501,000 | 4.00% |
| First Light Asset Management, LLC | 658,145 | $35,790,000 | 3.16% |
| Altium Capital Management LP | 126,000 | $6,852,000 | 2.29% |
| Nantahala Capital Management | 816,830 | $44,419,000 | 1.96% |
| Orbimed Advisors | 1,679,417 | $91,327,000 | 1.48% |
| CHI Advisors LLC | 62,229 | $3,384,000 | 1.44% |
| Parkman Healthcare Partners LLC | 72,690 | $3,953,000 | 1.16% |